Skip to main content
. 2016 May 1;6(5):937–956.

Table 2.

Induction of cell cycle changes by anti-RON ADC Zt/g4-DM1 in pancreatic cancer cell lines*

PDAC cell lines Changes of cells cycles after Zt/g4-dM1 treatment (%)

G0/G1 phase S phase G2M phase Polyploidy

0 h 12 h 24 h 36 h 0 h 12 h 24 h 36 h 0 h 12 h 24 h 36 h 0 h 36 h
L3.6pl 45.24 33.91 8.55 7.59 23.25 26.01 16.44 22.45 23.58 34.01 53.34 54.05 7.93 14.95
BxPc-3 44.58 24.55 7.05 7.03 21.31 14.09 16.00 15.73 31.51 50.06 61.39 62.36 2.61 14.85
FG 42.23 31.73 26.01 22.48 21.92 20.65 18.15 17.14 27.49 36.85 46.31 50.74 8.36 9.64
Average 44.02 ± 1.58 30.06 ± 4.90 13.87 ± 10.5 12.16 ± 8.76 22.16 ± 0.99 20.25 ± 5.97 16.86 ± 1.14 18.44 ± 3.54 27.53 ± 3.97 40.31 ± 8.57 53.68 ± 7.55 55.73 ± 6.00 6.30 ± 3.20 13.15 ± 3.04
*

Individual PDAC cell lines were treated with 5 µg/ml of Zt/g4-DM1 for various time intervals followed by flow cytometric analysis to determine their cell cycles as previously described [16].